Company / Operating Cash Flow per Share
Ensysce Biosciences, Inc. Operating Cash Flow per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$5.53
FY2025
5-year range
-$51.40 / -$5.53
FY2022-FY2025
Trend
+89.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $-5.53.
Based on SEC 10-K filings.
-5.53 in FY2025.
Improved from $-33.47 to $-5.53 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 89.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.53 | +89.2% |
| FY2024 | -$51.40 | -53.6% |
| FY2023 | -$33.47 | -26.3% |
| FY2022 | -$26.51 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026